
Larimar Therapeutics, Inc.
LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31
Reports and events: 239 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-08-0817:10 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-030904 |
| 2019-08-0816:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-216900 |
| 2019-06-1317:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-19-172590 |
| 2019-05-3007:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-160233 |
| 2019-05-0917:01 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-018086 |
| 2019-05-0916:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-143016 |
| 2019-04-2617:19 ET | DEF 14A | Proxy statementPeriod 2019-06-13 | 0001193125-19-122675 |
| 2019-04-0416:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-097949 |
| 2019-03-1417:25 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-007863 |
| 2019-03-1116:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-070841 |
| 2019-02-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-19-042548 |
| 2019-01-1707:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-010961 |
| 2018-11-2607:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-333393 |
| 2018-11-0917:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-18-323890 |
| 2018-11-0916:31 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-028944 |
| 2018-11-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-320926 |
| 2018-08-0916:32 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001193125-18-244422 |
| 2018-08-0716:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-241169 |
| 2018-08-0216:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-236631 |
| 2018-06-2817:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-207787 |
| 2018-06-2507:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-201664 |
| 2018-06-0717:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-18-186943 |
| 2018-05-3017:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-178715 |
| 2018-05-1016:34 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001193125-18-159281 |
| 2018-05-0816:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-155978 |
| 2018-04-1817:23 ET | DEF 14A | Proxy statementPeriod 2018-06-06 | 0001193125-18-121231 |
| 2018-03-0916:44 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001193125-18-077456 |
| 2018-03-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-072113 |
| 2018-01-0516:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-004559 |
| 2017-11-0717:14 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001193125-17-335910 |
| 2017-11-0716:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-335861 |
| 2017-10-1217:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-17-308904 |
| 2017-08-0916:28 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001193125-17-252840 |
| 2017-08-0816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-251371 |
| 2017-06-2316:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-17-211752 |
| 2017-05-0916:30 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001193125-17-164257 |
| 2017-05-0916:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-164232 |
| 2017-05-0416:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-17-158697 |
| 2017-04-2816:27 ET | DEF 14A | Proxy statementPeriod 2017-06-21 | 0001193125-17-148291 |
| 2017-03-1016:07 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001193125-17-078784 |
| 2017-03-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-076883 |
| 2016-11-0916:32 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001193125-16-764420 |
| 2016-11-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-764348 |
| 2016-08-0518:07 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001193125-16-672131 |
| 2016-08-0416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-671803 |
| 2016-07-1917:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-651297 |
| 2016-07-0116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-16-640536 |
| 2016-05-1016:53 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001193125-16-585718 |
| 2016-05-1016:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-585593 |
| 2016-05-0417:23 ET | DEF 14A | Proxy statementPeriod 2016-06-30 | 0001193125-16-577958 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.